Anticancer treatment with chemotherapy, immunotherapy, hormonal therapy, biologic therapy, or with any other anticancer therapy within 28 days prior to Cycle 1 Day 1 (C1D1) of trial drug treatment; (6 weeks for nitrosurea or mitomycin C).